Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Other Non-Current Assets (2023 - 2025)

Historic Other Non-Current Assets for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to $111.6 million.

  • Ardent Health's Other Non-Current Assets fell 1872.66% to $111.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.6 million, marking a year-over-year decrease of 1872.66%. This contributed to the annual value of $143.0 million for FY2024, which is 281.23% down from last year.
  • According to the latest figures from Q3 2025, Ardent Health's Other Non-Current Assets is $111.6 million, which was down 1872.66% from $111.2 million recorded in Q2 2025.
  • Ardent Health's 5-year Other Non-Current Assets high stood at $147.1 million for Q4 2023, and its period low was $111.2 million during Q2 2025.
  • Moreover, its 3-year median value for Other Non-Current Assets was $137.3 million (2024), whereas its average is $130.2 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first tumbled by 281.23% in 2024, then crashed by 2305.13% in 2025.
  • Ardent Health's Other Non-Current Assets (Quarter) stood at $147.1 million in 2023, then fell by 2.81% to $143.0 million in 2024, then fell by 21.95% to $111.6 million in 2025.
  • Its Other Non-Current Assets stands at $111.6 million for Q3 2025, versus $111.2 million for Q2 2025 and $116.9 million for Q1 2025.